Kaempferol

Also called kaempferol aglycone, kaempferol glycosides, KMP, quinoa kaempferol.

The short answer

From 8 sources

Kaempferol is a dietary flavonoid. Nearly all human trials come from one company, Otsuka Pharmaceutical, using 10 mg doses. Small crossover trials found lower oxygen use and heart rate during exercise and more daily steps, but 400-m race times did not improve. A 4-week trial of 50 mg/day found no safety problems.

Key facts

Exercise oxygen use
A single 10 mg dose lowered oxygen uptake during submaximal cycling and lengthened time to exhaustion at 100% VO2max vs placebo in 16 trained athletes1
Race times
In 13 male athletes running two 400-m races, 10 mg did not change race times but lowered heart and breathing rates and muscle-damage markers in the second run2
Daily activity and sleep
Over 2 weeks, 10 mg/day raised daily steps and lowered heart rate vs placebo in 33 office workers, and device-measured sleep quality improved3
Safety
50 mg/day, about five times estimated dietary intake, caused no changes in blood, urine or blood pressure and no adverse events over 4 weeks in 48 adults4
Absorption from food
In 8 adults eating endive with 9 mg of kaempferol, blood levels peaked at a mean 0.1 µM after 5.8 hours and 1.9% of the dose reached the urine in 24 hours7
Who funds it
Every trial on this page lists Otsuka Pharmaceutical employees as authors12345

What it is

Kaempferol is a flavonol found in kale, beans, tea, broccoli and quinoa, sold as a purified supplement.

How it works

Proposed

In cell studies by the same group, kaempferol increased mitochondrial ATP production under low oxygen. Trial authors propose that this improves oxygen use during exercise and shifts the nervous system toward rest (lower heart rate, higher heart rate variability). These ideas are not confirmed.13

Forms, side by side

2 forms named in our sources. The rest show what our data holds, and say plainly where it holds nothing yet.

Kaempferol forms compared

2 forms
Kaempferol forms compared: 2 forms by 3 attributes. Empty cells are labelled No data yet, or Not graded in the evidence row.
2 formsAglycone capsulesFrom foods
Absorption in peopleNot reported in the trial abstracts.413In 8 adults eating endive (9 mg kaempferol), plasma kaempferol peaked at a mean 0.1 µM after 5.8 hours and 1.9% of the dose was excreted in urine within 24 hours, mostly as kaempferol-3-glucuronide.7
GI toleranceNo adverse events at 50 mg/day for 4 weeks.413Part of normal diets.6
Studied forExercise, activity, sleep, safetyAbsorption (pharmacokinetic study); population studies of diet
  1. Kaempferol aglycone capsules
    Absorption in people
    Not reported in the trial abstracts.413
    GI tolerance
    No adverse events at 50 mg/day for 4 weeks.413
    Studied for
    Exercise, activity, sleep, safety
  2. Kaempferol from foods
    Absorption in people
    In 8 adults eating endive (9 mg kaempferol), plasma kaempferol peaked at a mean 0.1 µM after 5.8 hours and 1.9% of the dose was excreted in urine within 24 hours, mostly as kaempferol-3-glucuronide.7
    GI tolerance
    Part of normal diets.6
    Studied for
    Absorption (pharmacokinetic study); population studies of diet
Every cell holds data from a cited page; citation numbers link to the page that holds them.Scroll the table for every column

What the human research says

Human trials only, one row per outcome. The form line shows what each trial actually tested. Grades follow our evidence-grading policy.

Trial map

4 graded outcomes, largest study first

4 graded outcomes: 3 improved, 1 mixed. The largest, a 2025 open-label trial of 387 people on Weather-related headache and discomfort, found an improvement.

1Weather-related headache and discomfort

Improved · Grade D · Open-label trial, 387 people, 2025

Adults with moderate weather-related symptoms (Japan); 387 of 458 analyzed

Dose, result and source
Every graded outcome on this page, largest study first
OutcomeFoundPeopleStudyWho was studied
Weather-related headache and discomfortImproved387Grade D · Open-label trial, 2025Adults with moderate weather-related symptoms (Japan); 387 of 458 analyzed
Daily steps, heart rate and sleep qualityImproved33Grade D · Crossover RCT, 2024City office workers, 17 men and 16 women (Japan)
Oxygen uptake and endurance during cyclingImproved16Grade D · Crossover RCT, 2025Well-trained male university athletes (Japan)
Race times and physiological load in repeated 400-m runsMixed13Grade D · Crossover RCT, 2024Male university athletes (about 21 years old, Japan)
Each circle is one graded outcome on this page, numbered from the largest study down, and placed by how many people it studied (log scale). It shows who was studied and what was found, not advice about your dose.

Every graded row

4 rows

Showing 4 of 4 outcomes. Human trials only.

Grade DWeather-related headache and discomfortWeather-related painFewer headaches (uncontrolled)Open-label trial
n 387 · 2025

Improved Headache frequency (Cohen's d 0.61), duration and severity fell from the pre-intervention period; over 80% reported improvement.

Design
Open-label trial, n = 387, 2025
Population
Adults with moderate weather-related symptoms (Japan); 387 of 458 analyzed
Form
Kaempferol, no control group
Dose
10 mg/day
Duration
4 weeks
Source
Reference 5 · PubMed 40705051 (opens PubMed)
Grade DDaily steps, heart rate and sleep qualitySleep and activityMore steps, better sleep scoresCrossover RCT
n 33 · 2024

Improved Daily steps and distance rose, heart rate fell at each activity level, and sleep quality measured by a Fitbit improved during kaempferol intake vs placebo.

Design
Crossover RCT, n = 33, 2024
Population
City office workers, 17 men and 16 women (Japan)
Form
Kaempferol vs placebo
Dose
10 mg/day
Duration
2 weeks per period, 7-day washout
Source
Reference 3 · PubMed 39155930 (opens PubMed)
Grade DOxygen uptake and endurance during cyclingEnduranceLower oxygen costCrossover RCT
n 16 · 2025

Improved VO2 and breathing rate were lower at 25%, 50% and 75% VO2max, and exercise time at 100% VO2max was longer (p < 0.05 vs placebo); lactate and respiratory quotient did not rise.

Design
Crossover RCT, n = 16, 2025
Population
Well-trained male university athletes (Japan)
Form
Kaempferol vs placebo
Dose
10 mg once
Duration
Single dose
Source
Reference 1 · PubMed 40346019 (opens PubMed)
Grade DRace times and physiological load in repeated 400-m runsSprint performanceNo faster race timesCrossover RCT
n 13 · 2024

Mixed Race times did not differ; heart rate, breathing rate, myoglobin and AST were lower after the second run (p < 0.05).

Design
Crossover RCT, n = 13, 2024
Population
Male university athletes (about 21 years old, Japan)
Form
Kaempferol vs placebo
Dose
10 mg once
Duration
Single dose
Source
Reference 2 · PubMed 39619966 (opens PubMed)

What the numbers add up to

Each point is worked out from the data and the sources numbered on this page, with the arithmetic shown under it. It adds no new data and is not medical advice.

One company's research program

All five human studies here involve Otsuka Pharmaceutical staff, and none has been repeated by an independent group.12345

How we got this: Author affiliations and conflict statements

Body signals, not results

Kaempferol changed heart rate, breathing and oxygen use, but the one trial with a real performance outcome (race time) found no difference.12

How we got this: Comparison of the exercise trials

Diet links are observational

In US national survey data, each extra 5 mg/day of dietary kaempferol was linked to 7% lower odds of kidney damage in adults with overweight or obesity; this cannot show cause and effect.6

How we got this: NHANES analysis

Studied doses

Doses used in research, shown against the official limits. They describe the studies, not a recommendation for you.

Studied doses in research, not advice. These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.

Doses studied in human trials

Doses studied in human trials ranged from a single 10 mg dose before exercise to 10 mg/day for 2-4 weeks; a safety trial used 50 mg/day for 4 weeks, about five times estimated dietary intake. These are research doses, not recommendations.1354

When trials measured an effect

3 outcomes
How long trials ran before effects were measured
OutcomeMeasured atBasis
Oxygen use and endurance during cyclingSame day, after a single 10 mg doseSingle-dose crossover trial in 16 trained athletes1
Daily steps and sleep quality (wearable)Within each 2-week intake period10 mg/day crossover in 33 office workers, tracked by a Fitbit through each 2-week period3
Weather-related headacheWeek 4 (end of an uncontrolled study)Questionnaires before and after 4 weeks of 10 mg/day; no placebo group5
When each outcome was assessed in the cited trials. It is not a promise of when anyone will notice a change.

Interactions and safety

Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.

Interactions

0 agents

None found in our sources.

Check with what you take

Kept on this device only

Add what you take. We list every interaction our evidence profiles cite between Kaempferol and your picks, and between your picks.

Most cited:

Add a supplement or medicine you take to check it against Kaempferol.

Starting from one medicine? The interaction checker rates how serious each pair is, on a curated list of 19 entries for 11 medicines. This cabinet has no severity rating: it lists every interaction row our supplement pages cite.

Not medical advice, and no dosing advice. An empty result means no row we cite names that pair, by name or through a drug class we can link the medicine to, not that a combination is safe. Where our sources name only a group of medicines we cannot match, the cabinet says so. Ask your pharmacist before you combine supplements and medicines.

Who should be careful

4 groups
Athletes expecting faster times
In the only race-performance trial, 10 mg did not change 400-m race times.2
Drug interactions
No published human drug-interaction studies were found; LiverTox and LactMed have no kaempferol entry, and the 4-week safety trial did not test medicines.4
Pregnancy and breastfeeding
No reliable data on supplements: none of the cited trials included pregnant or breastfeeding women. LactMed's ginkgo entry reports kaempferol from ordinary diets in the breast milk of 17 mothers at 7.8-71.4 nmol/L; supplement doses have not been studied.48
Higher doses
Safety has been tested only up to 50 mg/day for 4 weeks in healthy adults.4
Talk to your pharmacist or clinician before starting a supplement, especially if you take prescription medicines.

How to read the label

What to check on the Supplement Facts panel.

How to read the label

2 checks
Aglycone dose

The trials used kaempferol aglycone (the free form), at 10 mg in performance and sleep studies and 50 mg in the safety study.41

Food comparison

The safety trial authors estimate that 50 mg is about five times typical dietary intake, so a 10 mg capsule is roughly a day of normal dietary kaempferol.4

Frequently asked questions

Short answers to common questions; the numbers link to the sources below.

Common questions

6 answers
Does kaempferol help sleep?

One 2-week crossover trial in 33 office workers found better sleep quality on a wearable device. It has not been repeated.3

Is kaempferol from food as good as a supplement?

No trial has compared them. The trials used 10 mg capsules of kaempferol aglycone; from endive, 9 mg of kaempferol reached a peak blood level of 0.1 µM after about 6 hours in 8 adults.137

Is kaempferol safe?

A 4-week placebo-controlled trial of 50 mg/day in 48 healthy adults found no changes in blood or urine tests and no adverse events. Longer use is untested.4

Does kaempferol interact with medicines?

No human interaction studies exist, and the 4-week safety trial did not test medicines. The 50 mg safety dose is about five times estimated dietary intake, so the 10 mg trial dose is close to normal dietary amounts.4

What does kaempferol do?

In small company-run trials, 10 mg lowered heart rate and oxygen use during exercise and raised daily steps. It did not make athletes run faster.123

Who studied kaempferol in people?

Almost all trials come from researchers at Otsuka Pharmaceutical, which limits independence.134

What changed

Every dated change to this page: what changed, who made it and why.

Change log

3 entries
Dated changes to this page
DateChangeWho and why
key facts, forms, who should avoid, FAQ, questions, time to effect, relatedSearched PubMed for kaempferol trials and meta-analyses through October 2026: no human trial newer than the 2025 rows exists (an August 2025 correction to the cycling trial fixes a figure and a table but not the reported results), so the evidence table is unchanged. Added a human absorption study (9 mg from endive; peak 0.1 µM at 5.8 h, 1.9% in urine) to the food form, key facts and FAQ, and LactMed's ginkgo entry (kaempferol from ordinary diets measured in breast milk) to a rewritten pregnancy and breastfeeding note. Interaction check: LiverTox and LactMed have no kaempferol entry and PubMed lists no human drug-interaction study; the list stays empty. Added FAQ items on interactions and food versus supplements, time-to-effect rows, page questions and a performance goal-hub link.Writer: Kymata Health EditorialTrigger: A–Z audit against docs/supplements/AUDIT-STANDARD.md
allInitial editorial evidence review (first draft). Every PMID checked against NCBI E-utilities esummary (titles and years taken from the record, none retracted) and the abstract read for each cited row. Studied doses are reported as research doses, not dosing advice.Writer: Kymata Health EditorialTrigger: new page
evidence, safetyAdversarial review: single 33-person crossover (activity and sleep) regraded C to D per the methodology grade rules.Writer: Kymata Health EditorialTrigger: adversarial review

Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.